PML Expression in Soft Tissue Sarcoma: Prognostic and Predictive Value in Alkylating Agents/Antracycline-Based First Line Therapy

Journal of Cellular Physiology - United States
doi 10.1002/jcp.22889
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Prognostic Factors in Soft Tissue Sarcoma

2011English

Oncological Outcome and Prognostic Factors in the Therapy of Soft Tissue Sarcoma of the Extremities

Orthopedic Reviews
OrthopedicsSports Medicine
2012English

Prognostic Value of Monocyte and Neutrophils to Lymphocytes Ratio in Patients With Metastatic Soft Tissue Sarcoma

Oncotarget
Oncology
2015English

Intraoperative Radiation Therapy (IORT) in Soft-Tissue Sarcoma

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

GeDDiS: Insight Into Frontline Therapy in Soft Tissue Sarcoma

The Lancet Oncology
Oncology
2017English

Immunotherapy in Soft-Tissue Sarcoma

Current Oncology
Oncology
2020English

The Value of Trabectedin in the Treatment of Soft Tissue Sarcoma

Therapeutics and Clinical Risk Management
2016English

Genomic-Guided Precision Therapy for Soft Tissue Sarcoma

ESMO Open
Cancer ResearchOncology
2020English

Tailoring Surgical Therapy for Extremity Soft Tissue Sarcoma

Annals of Surgical Oncology
OncologySurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy